Bumpus Namandje sold RXRX
June 18, 2026 · Form 4 insider transaction
Bumpus Namandje sold 3,963 shares of Recursion Pharmaceuticals, Inc. at $3.18 per share, a transaction worth $12.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Disposed (sell-side)
Shares
3,963
Price
$3.18
Total value
$12.6K
InsiderBumpus Namandje
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateJune 18, 2026
Filing dateJune 22, 2026
Shares owned after127,632
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 3, 2026.